Israeli skin care firm plans to raise $75 million in New York IPO
Foamix, based in Rehovot, files draft prospectus for offering that would value company at less than $200 million.
Foamix, which is using a proprietary foam technology to develop topical treatments for acne, impetigo and other skin conditions, is planning to raise $75 million in an initial public offering in New York.
register with haaretz
Like us on Facebook and get articles directly in your news feed